US Stock MarketDetailed Quotes

GRX Gabelli Healthcare & WellnessRx Trust

Watchlist
  • 11.100
  • +0.040+0.36%
Trading Sep 9 09:30 ET
188.40MMarket Cap-4021P/E (TTM)

Gabelli Healthcare & WellnessRx Trust Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q2)Jun 30, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q2)Jun 30, 2021
Assets
Cash cash equivalents and federal funds sold
-85.56%5.79K
-95.31%2.37K
-95.31%2.37K
138.72%40.08K
--50.49K
--50.49K
518.38%16.79K
----
----
18.51%2.72K
-Cash and cash equivalents
-85.56%5.79K
-95.31%2.37K
-95.31%2.37K
138.72%40.08K
--50.49K
--50.49K
518.38%16.79K
----
----
18.51%2.72K
Receivables
5.18%1.4M
-88.35%772.25K
-88.35%772.25K
161.60%1.33M
1,292.16%6.63M
1,292.16%6.63M
-62.92%507.56K
-90.68%476K
-90.68%476K
134.14%1.37M
Prepaid assets
9.50%7.25K
73.41%6.47K
73.41%6.47K
107.78%6.62K
310.90%3.73K
310.90%3.73K
-11.57%3.19K
-87.81%908
-87.81%908
14.19%3.61K
Derivative assets
----
----
----
--2.71K
----
----
----
----
----
----
Deferred costs
14.68%178.3K
0.00%155.48K
0.00%155.48K
0.00%155.48K
7.87%155.48K
7.87%155.48K
10.34%155.48K
140.96%144.14K
140.96%144.14K
28.24%140.91K
Total assets
-12.93%230.98M
-3.88%239.04M
-3.88%239.04M
-9.02%265.29M
-29.11%248.7M
-29.11%248.7M
-3.61%291.59M
22.46%350.84M
22.46%350.84M
20.15%302.5M
Liabilities
Payables
-2.21%538.52K
-82.84%660.88K
-82.84%660.88K
48.17%550.71K
-41.49%3.85M
-41.49%3.85M
-36.09%371.68K
62.53%6.58M
62.53%6.58M
23.36%581.58K
-Accounts payable
4.31%41.23K
-99.10%31.84K
-99.10%31.84K
-11.07%39.52K
-43.37%3.53M
-43.37%3.53M
-83.43%44.44K
70.90%6.23M
70.90%6.23M
787.42%268.18K
-Other payable
-2.72%497.3K
94.19%629.04K
94.19%629.04K
56.21%511.18K
-8.20%323.94K
-8.20%323.94K
4.41%327.24K
-12.84%352.86K
-12.84%352.86K
-28.97%313.4K
Long term debt and capital lease obligation
--67.45K
--384
--384
----
----
----
----
--68.5K
--68.5K
--92.21K
Preferred securities outside stock equity
-14.49%54.69M
33.30%53.32M
33.30%53.32M
-20.06%63.96M
-50.00%40M
-50.00%40M
100.00%80M
100.00%80M
100.00%80M
--40M
Total liabilities
-14.18%55.52M
23.14%54.23M
23.14%54.23M
-19.66%64.7M
-49.31%44.04M
-49.31%44.04M
97.25%80.53M
96.05%86.88M
96.05%86.88M
7,431.11%40.83M
Shareholders'equity
Share capital
-6.11%109.14M
-8.60%114.34M
-8.60%114.34M
-5.78%116.25M
-1.35%125.1M
-1.35%125.1M
-3.18%123.38M
-3.39%126.82M
-3.39%126.82M
-27.13%127.43M
-common stock
-6.11%109.14M
-8.60%114.34M
-8.60%114.34M
-5.78%116.25M
-1.35%125.1M
-1.35%125.1M
-3.18%123.38M
-3.39%126.82M
-3.39%126.82M
-7.55%127.43M
Retained earnings
-21.38%66.32M
-11.41%70.47M
-11.41%70.47M
-3.80%84.35M
-41.99%79.55M
-41.99%79.55M
-34.68%87.68M
23.65%137.13M
23.65%137.13M
75.83%134.24M
Total stockholders'equity
-12.53%175.46M
-9.70%184.81M
-9.70%184.81M
-4.96%200.59M
-22.47%204.65M
-22.47%204.65M
-19.34%211.06M
8.99%263.95M
8.99%263.95M
4.16%261.67M
Total equity
-12.53%175.46M
-9.70%184.81M
-9.70%184.81M
-4.96%200.59M
-22.47%204.65M
-22.47%204.65M
-19.34%211.06M
8.99%263.95M
8.99%263.95M
4.16%261.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q2)Jun 30, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q2)Jun 30, 2021
Assets
Cash cash equivalents and federal funds sold -85.56%5.79K-95.31%2.37K-95.31%2.37K138.72%40.08K--50.49K--50.49K518.38%16.79K--------18.51%2.72K
-Cash and cash equivalents -85.56%5.79K-95.31%2.37K-95.31%2.37K138.72%40.08K--50.49K--50.49K518.38%16.79K--------18.51%2.72K
Receivables 5.18%1.4M-88.35%772.25K-88.35%772.25K161.60%1.33M1,292.16%6.63M1,292.16%6.63M-62.92%507.56K-90.68%476K-90.68%476K134.14%1.37M
Prepaid assets 9.50%7.25K73.41%6.47K73.41%6.47K107.78%6.62K310.90%3.73K310.90%3.73K-11.57%3.19K-87.81%908-87.81%90814.19%3.61K
Derivative assets --------------2.71K------------------------
Deferred costs 14.68%178.3K0.00%155.48K0.00%155.48K0.00%155.48K7.87%155.48K7.87%155.48K10.34%155.48K140.96%144.14K140.96%144.14K28.24%140.91K
Total assets -12.93%230.98M-3.88%239.04M-3.88%239.04M-9.02%265.29M-29.11%248.7M-29.11%248.7M-3.61%291.59M22.46%350.84M22.46%350.84M20.15%302.5M
Liabilities
Payables -2.21%538.52K-82.84%660.88K-82.84%660.88K48.17%550.71K-41.49%3.85M-41.49%3.85M-36.09%371.68K62.53%6.58M62.53%6.58M23.36%581.58K
-Accounts payable 4.31%41.23K-99.10%31.84K-99.10%31.84K-11.07%39.52K-43.37%3.53M-43.37%3.53M-83.43%44.44K70.90%6.23M70.90%6.23M787.42%268.18K
-Other payable -2.72%497.3K94.19%629.04K94.19%629.04K56.21%511.18K-8.20%323.94K-8.20%323.94K4.41%327.24K-12.84%352.86K-12.84%352.86K-28.97%313.4K
Long term debt and capital lease obligation --67.45K--384--384------------------68.5K--68.5K--92.21K
Preferred securities outside stock equity -14.49%54.69M33.30%53.32M33.30%53.32M-20.06%63.96M-50.00%40M-50.00%40M100.00%80M100.00%80M100.00%80M--40M
Total liabilities -14.18%55.52M23.14%54.23M23.14%54.23M-19.66%64.7M-49.31%44.04M-49.31%44.04M97.25%80.53M96.05%86.88M96.05%86.88M7,431.11%40.83M
Shareholders'equity
Share capital -6.11%109.14M-8.60%114.34M-8.60%114.34M-5.78%116.25M-1.35%125.1M-1.35%125.1M-3.18%123.38M-3.39%126.82M-3.39%126.82M-27.13%127.43M
-common stock -6.11%109.14M-8.60%114.34M-8.60%114.34M-5.78%116.25M-1.35%125.1M-1.35%125.1M-3.18%123.38M-3.39%126.82M-3.39%126.82M-7.55%127.43M
Retained earnings -21.38%66.32M-11.41%70.47M-11.41%70.47M-3.80%84.35M-41.99%79.55M-41.99%79.55M-34.68%87.68M23.65%137.13M23.65%137.13M75.83%134.24M
Total stockholders'equity -12.53%175.46M-9.70%184.81M-9.70%184.81M-4.96%200.59M-22.47%204.65M-22.47%204.65M-19.34%211.06M8.99%263.95M8.99%263.95M4.16%261.67M
Total equity -12.53%175.46M-9.70%184.81M-9.70%184.81M-4.96%200.59M-22.47%204.65M-22.47%204.65M-19.34%211.06M8.99%263.95M8.99%263.95M4.16%261.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----Unqualified Opinion----Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg